A carregar...

Tumor suppressor maspin as a modulator of host immune response to cancer

Despite the promising clinical outcome, the primary challenge of the curative cancer immunotherapy is to overcome the dichotomy of the immune response: tumor-evoked immunostimulatory versus tumor-induced immunosuppressive. The goal needs to be two-fold, to re-establish sustainable antitumor-cancer i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Bosn J Basic Med Sci
Main Authors: Dzinic, Sijana H., Bernardo, M. Margarida, Oliveira, Daniel S. M., Wahba, Marian, Sakr, Wael, Sheng, Shijie
Formato: Artigo
Idioma:Inglês
Publicado em: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4690435/
https://ncbi.nlm.nih.gov/pubmed/26614844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17305/bjbms.2015.783
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!